Filter News
Area of Research
- (-) Nuclear Science and Technology (7)
- Advanced Manufacturing (18)
- Biology and Environment (22)
- Building Technologies (1)
- Clean Energy (84)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (8)
- Electricity and Smart Grid (1)
- Fusion and Fission (3)
- Fusion Energy (1)
- Isotopes (3)
- Materials (51)
- Materials for Computing (8)
- National Security (21)
- Neutron Science (67)
- Quantum information Science (2)
- Sensors and Controls (2)
- Supercomputing (36)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (2)
- (-) Biomedical (2)
- (-) Neutron Science (3)
- Advanced Reactors (6)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Fusion (2)
- Isotopes (3)
- Materials Science (1)
- Molten Salt (3)
- Nuclear Energy (17)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Researchers at the Department of Energy’s Oak Ridge National Laboratory are refining their design of a 3D-printed nuclear reactor core, scaling up the additive manufacturing process necessary to build it, and developing methods
Oak Ridge National Laboratory researchers working on neutron imaging capabilities for nuclear materials have developed a process for seeing the inside of uranium particles – without cutting them open.
OAK RIDGE, Tenn., Feb. 19, 2020 — The U.S. Department of Energy’s Oak Ridge National Laboratory and the Tennessee Valley Authority have signed a memorandum of understanding to evaluate a new generation of flexible, cost-effective advanced nuclear reactors.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.